Hussman Strategic Advisors Inc. Sells 105,000 Shares of Astrana Health, Inc. $ASTH

Hussman Strategic Advisors Inc. lowered its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 83.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,000 shares of the company’s stock after selling 105,000 shares during the quarter. Hussman Strategic Advisors Inc.’s holdings in Astrana Health were worth $595,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of ASTH. Pacer Advisors Inc. purchased a new stake in Astrana Health in the 3rd quarter valued at about $5,157,000. SteelPeak Wealth LLC raised its stake in shares of Astrana Health by 7.8% during the third quarter. SteelPeak Wealth LLC now owns 579,937 shares of the company’s stock valued at $16,441,000 after acquiring an additional 41,761 shares in the last quarter. Squarepoint Ops LLC boosted its holdings in shares of Astrana Health by 475.4% in the second quarter. Squarepoint Ops LLC now owns 95,557 shares of the company’s stock valued at $2,377,000 after purchasing an additional 78,951 shares during the period. First Citizens Bank & Trust Co. purchased a new stake in shares of Astrana Health in the second quarter valued at approximately $301,000. Finally, Rhenman & Partners Asset Management AB grew its stake in Astrana Health by 26.7% in the second quarter. Rhenman & Partners Asset Management AB now owns 190,000 shares of the company’s stock worth $4,727,000 after purchasing an additional 40,000 shares in the last quarter. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Price Performance

Shares of ASTH stock opened at $22.00 on Thursday. Astrana Health, Inc. has a 1-year low of $20.12 and a 1-year high of $39.97. The stock’s 50-day moving average is $24.55 and its 200 day moving average is $26.90. The company has a market cap of $1.24 billion, a P/E ratio of 115.80, a PEG ratio of 0.53 and a beta of 0.87. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.40 and a quick ratio of 1.40.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, November 6th. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.46). Astrana Health had a return on equity of 1.26% and a net margin of 0.33%.The firm had revenue of $956.05 million during the quarter, compared to the consensus estimate of $952.83 million. During the same quarter in the prior year, the firm posted $0.33 earnings per share. The business’s revenue for the quarter was up 99.7% compared to the same quarter last year. Research analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on ASTH shares. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Astrana Health in a research report on Monday, December 29th. BTIG Research decreased their price objective on Astrana Health from $50.00 to $45.00 and set a “buy” rating for the company in a report on Friday, November 7th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astrana Health in a research note on Tuesday, November 25th. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a report on Monday, January 12th. Finally, TD Cowen reduced their price target on shares of Astrana Health from $40.00 to $35.00 and set a “buy” rating for the company in a report on Monday, November 10th. Eight analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $41.33.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.